Risk of medicines: Counterfeit drugs

International Journal of Risk and Safety in Medicine

Volumn 16, Issue 3, 2004, Pages 181-190

  Akunyili, Dora Nkem ^a   Nnani, Ijeoma P C ^b,c  

^a National Agency for Food and Drug Administration and Control   (Nigeria)

^b NAFDAC ^*  (Nigeria)

^c National Agency for Food and Drug Administration and Control Abuja   (Nigeria)

Author keywords

Counterfeit medicines; Global anti counterfeiting organ; Pharmacovigilance; Safety of medicines

Indexed keywords

ABACAVIR; AMPICILLIN; ANALGESIC AGENT; ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ANTIPYRETIC AGENT; ANTIRETROVIRUS AGENT; ATORVASTATIN; AZATHIOPRINE; CARBAMAZEPINE; CEFTAZIDIME; CEFUROXIME; CHLOROQUINE; CLOBETASOL PROPIONATE; COUNTERFEIT DRUG; DICLOFENAC; DRUG; HIDERGINE; HORMONE; HUMAN GROWTH HORMONE; IMMUNOGLOBULIN; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; OLANZAPINE; OXYMETHOLONE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT HEPATITIS B VACCINE; RELIVERAN; SILDENAFIL; STEROID; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINECEF;

AFRICA; ARTICLE; ASIA; DRUG FATALITY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG LABELING; DRUG MARKETING; DRUG MONITORING; DRUG QUALITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ECONOMIC ASPECT; EUROPE; FEVER; FOOD AND DRUG ADMINISTRATION; HEALTH CARE; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HUMAN; HYPOTENSION; KIDNEY CALCIFICATION; KIDNEY CORTEX NECROSIS; KIDNEY FAILURE; LEGAL ASPECT; MALAISE; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROTOXICITY; NIGERIA; NONHUMAN; NORTH AMERICA; PHILIPPINES; PUBLIC HEALTH; RADIATION EXPOSURE; RASH; RISK ASSESSMENT; SIDE EFFECT; SOUTH AMERICA;

EID: 21444447761     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. D.N. Akunyili, Understanding the problem: The African perspective with special emphasis on Nigeria, The Global Forum on Pharmaceutical Anticounterfeiting, September 22-25. 2002.
2. S. Clarke, Investigation of counterfeit medicinal products in the United Kingdom, The Global Forum on Pharmaceutical Anticounterfeiting, September 22-25, 2002.
3. Counterfeit Drugs. Guidelines for the Development of Measures to Combat Counterfeit Drugs, WHO, 1999.
4. General Policy Topics, WHO Drug Information 6(2) (1992).
5. A.G. Gilman, J.G. Hardman and L.E. Limbert, Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th edn, McGraw-Hill, New York, 2001, p. 1359.
6. R.E. Gosselin, R.P. Smith and H. Hodge, Clinical Toxicology of Commercial Products, 5th edn, Williams and Wilkins, Baltimore, 1984.
7. D.M. Hopkins, L.T. Kontnik and M.T. Turnage, Counterfeiting Exposed. Protecting Your Brand and Customers, Wiley, 2000.
8. http://www.who.int/meidacentre/factsheets/2003/fs2.
9. T. Mura, Mission Report: Socialist Republic of Vietnam WHO Regional Office for the Western Pacific, 1992.
10. Myanmar Information Committee, Yangon Information sheet No. C-2891 (I), 2004.
11. P. Newton, Murder by fake drugs in SE Asia - Prevalence and prevention, The Global Forum on Pharmaceutical Anticounterfeiting, September 22-25, 2002.
12. P.N. Newton, S. Proux, M. Green, F. Smithuis, J. Rosendaal, S. Prakonpan, K. Chetivanich, M. Mayax, S. Ooareesuwan, J. Farrar, F. Nosten and N.J. White, Fake artesunate in South East Asia, Lancet 357 (2001), 1948-1950.
13. A. Pakharenko-Anderson, Building legislation and regulatory implementation environment: the Ukraine experience, The Global Forum on Pharmaceutical Anticounterfeiting, September 22-25, 2002.
14. G. Power, Combating Pharmaceutical Counterfeiting. GSK: A Case Study. SMI Conference Document 6th to 7th October 2003, the Hatton, London.
15. R. Rosen, Fighting counterfeit drugs in Russia: A Case Study, The Global Forum on Pharmaceutical Anticounterfeiting, September 22-25, 2002.
16. The Importance of Pharmacovigilance. Safety Monitoring of Medical Products. WHO, 2002.
17. WHO Expert Committee on Specifications for Pharmaceutical Preparations, Technical Reports Series 863, WHO, Geneva, 1996.
18. WHO Fact sheet No 275, November 11, 2003.
19. WHO Media Center, Fact Sheet no 275, November 2003.
20. E. Wondemagegnehu, Combating Pharmaceutical Fraud & Counterfeiting. SMI Conference Document 6th to 7th October 2003, the Hatton, London.